I undersøgelse X065 var doseringen initialt 20 mg dagligt, men kunne ved intolerans reduceres til indgivelse hver anden dag (20 mg hver anden dag).
In study X065, the starting dose was 20 mg/ d, which, in case of intolerance, could be decreased to every second day of administration.